Catalyst Pharmaceuticals Story

Catalyst Pharmaceuticals Inc -- USA Stock  

USD 2.51  0.01  0.4%

Macroaxis does not monitor all media channels or aggregates social signals for Catalyst Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Catalyst Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Catalyst Pharmaceuticals. Check also Catalyst Pharmaceuticals Hype Analysis, Catalyst Pharmaceuticals Correlation and Catalyst Pharmaceuticals Performance
Catalyst Pharmaceuticals, Inc. A Detailed Look at its Institutional ...
Catalyst Pharmaceuticals, Inc. reached 201.96 versus a 1year low price of 0.51. The stock was last seen 1.99 higher, reaching at 1.54 on Mar. 17, 2017. Stock Value Analysis Catalyst Pharmaceuticals, Inc. The Oracle Examiner The Catalyst Pharmaceuticals Inc Posts Quarterly Earnings Results ... Petro Global News 24

Read More...   

Story Momentum

This media report from postanalyst.com distributed on March 20, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 2.41% . The overall trading delta when the story was published against the current closing price is 45.18% .

Similar stores for Catalyst Pharmaceuticals

a day ago at http://postanalyst.com 
Catalyst Pharmaceuticals, Inc. -5.99 percent change took shares below their ...
news
Catalyst Pharmaceuticals, Inc. went up to recover about 166.62 percent since recording its record low price of 0.95. Catalyst Pharmaceuticals Incorporated Just Reported Increased Shorts - BZ Weekly
over two months ago at http://www.stocknewsgazette.com 
Catalyst Pharmaceuticals, Inc. Stock Nears 2.72 Still a Hold
news
Catalyst Pharmaceuticals, Inc. fell by -4.56 percent in Friday trading session from 2.85 to 2.72 and has now fallen 4 consecutive sessions. Unusual Activity Spotted in Catalyst Pharmaceuticals Inc and ... - Evergreen Caller
over three months ago at http://www.nasdaq.com 
Why Is Catalyst Pharmaceuticals Up 25.5 percent Since the Last Earnings Report
nasdaq News
Nasdaq - Jun 14, 2017 A month has gone by since the last earnings report for Catalyst Pharmaceuticals, Inc.CPRX . Shares have added about 25.5 percent in that time frame, outperforming the market. Analysts mean rating score stands at 2.00 while Catalyst Pharmaceuticals, Inc ... - Hot Stocks Point Analysts Take the Wheel on Catalyst Pharmaceutical Partners, Inc. NASDAQCPRX ... - Aiken Advocate
over six months ago at http://bentonbulletin.com 
Trading Watch Indicators in Review for Catalyst Pharmaceuticals Inc
news
Let take a closer look at some technical levels for Catalyst Pharmaceuticals Inc . The 14-day RSI is presently at 59.41, the 7-day is 50.33, and the 3-day is spotted at 41.49.

Did you try this?

Run My Watchlist Analysis Now
   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Hide  View All  Next  Launch My Watchlist Analysis

Shares Outstanding

Shares Outstanding Comparative Analysis
  Shares Outstanding 
      Catalyst Pharmaceuticals Comparables 
Catalyst Pharmaceuticals is currently under evaluation in shares outstanding category among related companies. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted bases which include exotic instruments such as options, or convertibles bonds.